Sampo Oyj A (SAMPO)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 9.222 |
|---|---|
| 52-week range | 8.634 – 10.390 |
| Return, 1 month / 3 months | −0.4% / −4.6% |
| Return, 1 year / 3 years | −1.6% / +40.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 60 |
| Volatility (1 year) | 16.8% |
| Worst drawdown (1 year) | -13.6% |
| Average daily value traded | 45.10M EUR |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sampo Oyj is a Finnish insurance group based in Helsinki. It provides property and casualty insurance to households and businesses, mainly through its If brand across the Nordic countries, and it also writes life insurance in Finland and the Baltic states. Its customers include private individuals, small and medium-sized enterprises and larger corporate clients, who buy cover for homes, vehicles, health, accidents and business risks.
The shares are listed on the Helsinki Exchange in Finland under the code SAMPO, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sampo Oyj A (SAMPO) trades on the Helsinki Exchange in Finland. It last closed at EUR 9.222 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 23 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.6% and over the last three months it fell 4.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.4% | ||
| From 52-week high | -10.7% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.6% | ||
| 6-month return | -1.1% | ||
| 12-month return, skipping the last month | -1.2% | ||
| Stability (higher is calmer) | 95 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.6% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 45.10M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | −0.4% |
| 3 months | −4.6% |
| 6 months | −1.1% |
| 1 year | −1.6% |
| 3 years | +40.4% |
| 5 years | +46.5% |
Signals
| 50-day / 200-day average | 9.297 / 9.185 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.109 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | EUR 0.3600 |
| 24 Apr 2025 | EUR 0.3400 |
| 26 Apr 2024 | EUR 1.8000 |
| 19 May 2023 | EUR 2.6000 |
| 19 May 2022 | EUR 4.1000 |
| 20 May 2021 | EUR 1.5465 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.